334 related articles for article (PubMed ID: 33013819)
21. γδ T Cells Participating in Nervous Systems: A Story of Jekyll and Hyde.
Li Y; Zhang Y; Zeng X
Front Immunol; 2021; 12():656097. PubMed ID: 33868300
[TBL] [Abstract][Full Text] [Related]
22. Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao Y; Niu C; Cui J
J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
[TBL] [Abstract][Full Text] [Related]
23. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
Maeurer MJ; Martin D; Walter W; Liu K; Zitvogel L; Halusczcak K; Rabinowich H; Duquesnoy R; Storkus W; Lotze MT
J Exp Med; 1996 Apr; 183(4):1681-96. PubMed ID: 8666926
[TBL] [Abstract][Full Text] [Related]
24. γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors.
Harmon C; Zaborowski A; Moore H; St Louis P; Slattery K; Duquette D; Scanlan J; Kane H; Kunkemoeller B; McIntyre CL; Scannail AN; Moran B; Anderson AC; Winter D; Brennan D; Brehm MA; Lynch L
Nat Cancer; 2023 Aug; 4(8):1122-1137. PubMed ID: 37474835
[TBL] [Abstract][Full Text] [Related]
25. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
Deniger DC; Maiti SN; Mi T; Switzer KC; Ramachandran V; Hurton LV; Ang S; Olivares S; Rabinovich BA; Huls MH; Lee DA; Bast RC; Champlin RE; Cooper LJ
Clin Cancer Res; 2014 Nov; 20(22):5708-19. PubMed ID: 24833662
[TBL] [Abstract][Full Text] [Related]
26. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization.
Zhan Y; Zheng L; Liu J; Hu D; Wang J; Liu K; Guo J; Zhang T; Kong D
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34283812
[TBL] [Abstract][Full Text] [Related]
27. γδ T Cells: Unexpected Regulators of Cancer Development and Progression.
Fleming C; Morrissey S; Cai Y; Yan J
Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933
[TBL] [Abstract][Full Text] [Related]
28. Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors.
Park JH; Kim HJ; Kim CW; Kim HC; Jung Y; Lee HS; Lee Y; Ju YS; Oh JE; Park SH; Lee JH; Lee SK; Lee HK
Nat Immunol; 2021 Mar; 22(3):336-346. PubMed ID: 33574616
[TBL] [Abstract][Full Text] [Related]
29. NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions.
Cazzetta V; Bruni E; Terzoli S; Carenza C; Franzese S; Piazza R; Marzano P; Donadon M; Torzilli G; Cimino M; Simonelli M; Bello L; Villa A; Tan L; Ravens S; Prinz I; Supino D; Colombo FS; Lugli E; Marcenaro E; Vivier E; Della Bella S; Mikulak J; Mavilio D
Cell Rep; 2021 Oct; 37(3):109871. PubMed ID: 34686325
[TBL] [Abstract][Full Text] [Related]
30. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
Paul S; Lal G
Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
32. Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.
Devaud C; Rousseau B; Netzer S; Pitard V; Paroissin C; Khairallah C; Costet P; Moreau JF; Couillaud F; Dechanet-Merville J; Capone M
Cancer Immunol Immunother; 2013 Jul; 62(7):1199-210. PubMed ID: 23619975
[TBL] [Abstract][Full Text] [Related]
33. CD8αβ+ γδ T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease.
Kadivar M; Petersson J; Svensson L; Marsal J
J Immunol; 2016 Dec; 197(12):4584-4592. PubMed ID: 27849165
[TBL] [Abstract][Full Text] [Related]
34. Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.
Urban EM; Chapoval AI; Pauza CD
Clin Dev Immunol; 2010; 2010():732893. PubMed ID: 20396597
[TBL] [Abstract][Full Text] [Related]
35. Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer.
Lo Presti E; Mocciaro F; Mitri RD; Corsale AM; Di Simone M; Vieni S; Scibetta N; Unti E; Dieli F; Meraviglia S
J Leukoc Biol; 2020 Aug; 108(2):749-760. PubMed ID: 32202356
[TBL] [Abstract][Full Text] [Related]
36. γδ T cells as a potential tool in colon cancer immunotherapy.
Ramutton T; Buccheri S; Dieli F; Todaro M; Stassi G; Meraviglia S
Immunotherapy; 2014; 6(9):989-99. PubMed ID: 25341120
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
Bai Z; Zhou Y; Ye Z; Xiong J; Lan H; Wang F
Front Immunol; 2021; 12():808964. PubMed ID: 35095898
[TBL] [Abstract][Full Text] [Related]
38. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.
Andreu-Ballester JC; Galindo-Regal L; Hidalgo-Coloma J; Cuéllar C; García-Ballesteros C; Hurtado C; Uribe N; Del Carmen Martín M; Jiménez AI; López-Chuliá F; Llombart-Cussac A
PLoS One; 2020; 15(12):e0243545. PubMed ID: 33326443
[TBL] [Abstract][Full Text] [Related]
39. Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β
Overgaard NH; Principe DR; Schachtschneider KM; Jakobsen JT; Rund LA; Grippo PJ; Schook LB; Jungersen G
Front Immunol; 2018; 9():1301. PubMed ID: 29930558
[TBL] [Abstract][Full Text] [Related]
40. Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
Saura-Esteller J; de Jong M; King LA; Ensing E; Winograd B; de Gruijl TD; Parren PWHI; van der Vliet HJ
Front Immunol; 2022; 13():915837. PubMed ID: 35784326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
